Singapore Bioimaging Consortium (SBIC)

	19 Apr 2013 “Intravital Multimodal Optical Imaging” Dr Vyacheslav Kalchenko Click here for more information

	09 Apr 2013 “Coupling of the Keap1-Nrf2 system to Autophagy” Dr Masaaki Komatsu Click here for more information

	04 Apr 2013 UK-Singapore Workshop on Cardiovascular and Diabetic Complications Download File

	01 Apr 2013 “Regulation of Cardiac Remodeling in Heart Failure and Skeletal Muscle Metabolism in Diabetes by Adiponectin : Mechanisms of action” Gary Sweeney Click here for more information

	27 Feb 2013 “Functional Nanoparticles for Molecular Imaging and Drug Delivery” Xu Chenjie Click here for more information

The Singapore Bioimaging Consortium (SBIC) aims to build a coordinated national programme for imaging research, bringing together substantial strengths in the physical sciences and engineering and those in the biomedical sciences. SBIC seeks to identify and consolidate the various bioimaging capabilities across local research institutes, universities and hospitals in order to speed the development of biomedical research discoveries.

SBIC's intramural programme comprises 9 research units, namely the Magnetic Resonance Imaging Group (MRIG*), Translational Molecular Imaging Group (TMIG*), Magnetic Resonance Spectroscopy and Metabolic Imaging (MRS/MI*) Group, PET Chemistry Group (PCG*), Bio-optical Imaging Group (BOIG*), Mechanistic Systems-biology NMR Group (MSNG*), Lab of Metabolic Medicine (LMM), Fat Metabolism and Stem Cell Group (FMSCG), Lab of Bioimaging Probe Development (LBPD), Biomedical Imaging Lab (BIL), and Quantitative Image Processing Group (QIPG). *MRIG, TMIG, MRS/MI Group, PCG, MSNG, and BOIG are collectively called the Lab of Molecular Imaging (LMI). More >>

--------------------------------------------------------------------------------------------------------------------------

SBIC has an Integrated Research Programme with core technology platforms including:

Development of chemical / biological probes
Metabolic phenotyping
In vitro and in vivo cellular imaging
SERS and optical imaging
MR spectroscopy and imaging
NanoSPECT and microPET imaging
Multimodality image processing and analysis

These technology platforms will be used to support research in biomedical areas such as cancer, metabolic diseases and regenerative medicine.

SBIC's current core project areas are:

Molecular understanding of diabetes and obesity
Brain dysfunction
Cell-based therapy development and diagnosis

Research Units >>